“showed a trend”

As for bacterial eradication, the meta-analyses showed a trend to increased microbiological clearance (RR 1.93, p=0.06), although it did not achieve statistical significance.

Patients with viral sepsis showed a trend of having lower LIGHT levels than patients with bacterial sepsis, albeit not statistically different ( p = 0.060).

The prognostic value of the score was validated in the CHOP Lenz cohort ( n = 181) and in the FFPE R-CHOP cohort ( n = 72), and showed a trend ( p = 0.06) in the Melnick cohort ( n = 69) ( Figure 4 B–D).

One-year follow-up Fibroid recurrence rates showed a trend toward lower rates in the 3D model group compared to the control group (1/55 [1.8%] vs. 7/55 [12.7%]; P = 0.060), approaching but not reaching statistical significance.

Baseline visual acuity was similar between groups (0.6 ± 0.6 vs 0.6 ± 0.6 logMAR, P = 0.92), while central macular thickness showed a trend toward difference (368.7 ± 172.0 vs 398.0 ± 169.4 μm, P = 0.06) (Table 1 ).

Patients who underwent BrM-directed therapy showed a trend toward longer survival from BrM diagnosis when compared with patients receiving supportive care only (median OS, 6.5 vs 0.8 months, P = . 060).

Finally, the stratified analysis according to the stage of melanoma revealed that PDE5i use was associated with a significantly increased risk for in situ melanoma (two studies, 16 , 20 adjusted RR =1.31, 95% CI =1.01–1.69, P =0.04, I 2 =69%; Figure 4B ), showed a trend toward increased risk for localized melanoma (three studies, 16 , 20 adjusted RR =1.13, 95% CI =0.99–1.29, P =0.06, I 2 =23%; Figure 4B ), and showed a trend toward reduced risk for nonlocalized melanoma (three studies, 16 , 20 adjusted RR =0.79, 95% CI =0.62–1.01, P =0.06, I 2 =0%; Figure 4B ).

In FU‐re‐UPH, an increased dosage of oral diuretics showed a trend toward association with re‐UPH ( P =0.06).

No association between WML and cognition was observed, whereas PDCP subject scores showed a trend‐level negative correlation with the DRS‐2 ( P = 0.060) as well as a negative correlation with PANDA ( P = 0.049) which persisted also after additional correction for WML ( P = 0.039).

muciniphila Muc T supplementation significantly increased Muc3 expression in the colon compared to HFD-fed mice ( Figure 4D ) and showed a trend towards increased Muc13 expression in the colon ( P = 0.06) ( Figure 4F ).

The MS-ECTresp showed a trend towards association with ECTresp (p < 0.06) in the German cohort for the continuous model (Supplementary Table 22 ).

Lower Glasgow Coma Scale showed a trend ( P = 0.06) as an independent predictor of ≥6‐mL growth but was an independent predictor of ICrH Expansion Scale change.

Trials with rare disease designation showed a trend toward longer SIS/ICFs (mean difference 5.3 pages, 95% CI: 0.2–10.8; p = 0.06).

In the univariate Cox regression analysis for PFS after the first series of treatments, prior transarterial chemoembolization (TACE) was significantly correlated with better PFS ( p = 0.01), and the absence of CD73 expression showed a trend toward better PFS ( p = 0.06).

At day 5, murine cells showed a trend toward an increased fusion index with 1 (Δ = 4.9%; p = .060) and 50 μM (Δ = 4.8%; p = .075), but not with 100 μM (Δ = 2.8%; p = .869).

Spontaneous inhibitory postsynaptic current (sIPSC) frequency recorded on M/T cells showed a trend toward increase after implicit learning (p=0.06, Kruskal-Wallis Anova followed by FDR-corrected permutation test, Enriched, n = 50 and Non-Enriched, n = 48) (for detailed statistics see Table 1 ), ( Figure 1H and Figure 1—source data 1 ) with no change in amplitude ( Table 1 , Enriched n = 48 and Non-Enriched, n = 46).

Among non-microscopic surgeons, satisfaction after SMILE was greater than with contact lenses ( p = 0.001) and showed a trend versus spectacles ( p = 0.060).

The distribution of bleeding sites showed a trend toward a difference between groups ( p = 0.06, Supplementary Table S5 )—gastrointestinal bleeding was more frequent in the NOAC group (55.3% vs. 30.0%), whereas transfusion-requiring events occurred more often in the APT group (40.0% vs. 10.5%).

coli challenge significantly ( p < 0.05) downregulated ZO-1 mRNA expression and showed a trend toward downregulating Occludin ( p = 0.06) and Claudin-1 ( p = 0.07) mRNA expression levels in the jejunum.

Three patients started/increased lipid-lowering treatment, while five patients maintained the same therapy and showed a trend of LDLc reduction (108.6 mg/dL vs. 88.6 mg/dL, p = 0.06).

The percentage of male participants showed a trend, with higher percentages predicting smaller effects ( b = −0.05, SE = 0.02, P = .060).

Only the presence of SST disease at baseline (HR 1.74, 95% CI 1.18-2.58, adjusted P = 0.05) was borderline significantly associated with PFS, whereas an increase in the number of brain lesions showed a trend of association that did not achieve statistical significance (HR 1.18, 95% CI 1.05-1.33, adjusted P = 0.06) ( Supplementary Table S10 , available at https://doi.org/10.1016/j.iotech.2025.101078 ).

Kaplan-Meier analysis showed a trend toward earlier fever in FQRE-positive patients (HR: 1.59, 95% CI: 0.98–2.59, p = 0.06) (Fig. 1 b).

Additionally, patients with low PlGF levels showed a trend toward increased adverse events compared to CHD women with non-reduced PlGF (66.7% vs 23.1%; P = 0.060; Figure 3B ), and those with a high sFlt-1/PlGF ratio also demonstrated a similar trend (62.5% vs 20.8%; P = 0.072; Figure 3C ).

Regarding acute rejection, pre-transplant LVAD showed a trend toward increased acute rejection with an HR of 1.63 (95% CI, 0.98–2.71; p=0.06), although this difference did not reach statistical significance.